Michael Wong - 09 Nov 2021 Form 3 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Vice President of Finance
Signature
/s/ Cyndi Baily, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
09 Nov 2021
Net transactions value
$0
Form type
3
Filing time
29 Nov 2021, 17:40:03 UTC
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCRT Employee Stock Option (right to buy) 09 Nov 2021 Common Stock 250,000 $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three month after 9/29/2021, subject to the Reporting Person's continued service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney